- Report
- May 2024
- 128 Pages
Global
From €2675EUR$2,999USD£2,300GBP
€3567EUR$3,999USD£3,067GBP
- Report
- May 2024
- 136 Pages
Global
From €2675EUR$2,999USD£2,300GBP
€3567EUR$3,999USD£3,067GBP
- Report
- February 2026
- 137 Pages
Australia
From €2675EUR$2,999USD£2,300GBP
€3567EUR$3,999USD£3,067GBP
- Report
- May 2024
- 132 Pages
Global
From €2675EUR$2,999USD£2,300GBP
€3567EUR$3,999USD£3,067GBP
- Report
- February 2024
- 112 Pages
Global
From €4237EUR$4,750USD£3,643GBP
- Report
- September 2026
China
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
United Kingdom
From €3559EUR$3,990USD£3,060GBP
- Report
- July 2024
- 200 Pages
Global
From €4415EUR$4,949USD£3,795GBP
- Report
- April 2023
- 147 Pages
Global
From €4415EUR$4,949USD£3,795GBP
- Report
- August 2025
- 118 Pages
Global
From €16052EUR$17,995USD£13,800GBP
- Report
- July 2025
- 89 Pages
Global
From €16052EUR$17,995USD£13,800GBP
- Report
- April 2025
- 20 Pages
Global
From €16052EUR$17,995USD£13,800GBP
- Clinical Trials
- March 2025
- 52 Pages
Global
From €3077EUR$3,450USD£2,646GBP
- Report
- December 2024
- 34 Pages
Global
From €3564EUR$3,995USD£3,064GBP
- Clinical Trials
- October 2024
- 183 Pages
Global
From €3077EUR$3,450USD£2,646GBP
- Report
- September 2024
- 115 Pages
Global
From €13376EUR$14,995USD£11,499GBP
- Clinical Trials
- August 2024
- 70 Pages
Global
From €3077EUR$3,450USD£2,646GBP
- Clinical Trials
- July 2024
- 458 Pages
Global
From €3077EUR$3,450USD£2,646GBP
- Report
- December 2023
- 78 Pages
Global
From €3118EUR$3,495USD£2,680GBP
- Report
- November 2023
- 1203 Pages
Global
From €2230EUR$2,500USD£1,917GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more